Company DynamicsExhibition Announcement

Express | Building Monkeypox Virus Nucleic Acid Detection Reagent System

According to the World Health Organization's website:

As of 13:00 on 21 May, 92 confirmed cases and 28 suspected cases of monkeypox under investigation have been reported to WHO from
12 non-monkeypox virus-endemic Member States (Table 1, Figure 1). No deaths have been reported to date.

Table 1. Cases of monkeypox from non-endemic countries reported to WHO from May 13-21, 2022 .

Figure 1. Geographical distribution of confirmed and suspected cases of non-endemic monkeypox from May 13-21, 2022

With the exception of this new outbreak, WHO continues to receive updates on ongoing monkeypox case reporting through the established surveillance mechanism for cases in endemic countries (Integrated Disease Surveillance and Response). Monkeypox is endemic in Benin, Cameroon, Central African Republic, Democratic Republic of Congo, Gabon, Ghana (found only in animals), Ivory Coast, Liberia, Nigeria, Republic of Congo, Sierra Leone and South Sudan. ‎
Based on the genetic sequence information of monkeypox virus, RENDU BIOTECHNOLOGY has established a nucleic acid detection system for monkeypox virus, which can not only specifically detect monkeypox virus, but also detect several viruses of the genus orpoxvirus (camelpox, cowpox, monkeypox, varicella, smallpox) and smallpox vaccine. The reagent system also contains human reference genes for sample quality control. At present, this product has obtained CE Certificate.

Contact Information



Address:Block A, building 15, NO.528 Ruiqing Road, East District, Zhangjiang High Tech Park, Shanghai, P.R .China

Copyright © Shanghai Rendu Biotechnology Co.,Ltd.